Answers are grounded in this paper and cite their sources.
This publication presents a clinical case of an extremely severe course of chronic tophaceous gout in a 44-year-old man, complicated by sepsis and multi-organ failure resulting in death. The patient had suffered from gout since 2010 but did not receive regular urate-lowering therapy for a long time due to poor adherence: he self-discontinued medications, did not monitor his uric acid levels, and uncontrollably took nonsteroidal anti-inflammatory drugs and colchicine. This led to disease progression with the formation of multiple tophi involving peripheral joints and the axial skeleton (vertebrae, ribs, craniovertebral junction), as well as the development of nephropathy and myelotoxicity. Multiple ulcerated and ruptured tophi became the entry point for multidrug-resistant microflora. In September 2025, the patient was hospitalized in severe condition with intense pain syndrome, syncopal episodes, acute hepatorenal failure, and sepsis (procalcitonin 151.6 ng/mL, CRP >96 mg/L). Despite hemodiafiltration, hemoadsorption with a Cytosorb column, combination antibiotic therapy, surgical debridement of purulent foci, nutritional support, and sympathomimetic support, the patient developed refractory septic shock with multi-organ dysfunction. Death occurred. This case demonstrates that refusal of adequate urate-lowering therapy and uncontrolled use of NSAIDs and colchicine in gout can lead to generalization of infection, sepsis, and fatal outcome.
No takes yet. Share an insight, caveat, or question.
Letaeva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: